Plan B GAO Investigation Sought By House Members
This article was originally published in The Tan Sheet
Executive Summary
House lawmakers are asking the General Accounting Office to examine communications between the White House and HHS regarding the Plan B emergency contraceptive switch application as part of a broader investigation into the decision to deny the switch
You may also be interested in...
FDA Comes Under Fire From Sen. Clinton Over Plan B Decision
Sen. Hillary Clinton (D-N.Y.) is calling for a hearing and separate GAO investigation into FDA's decision to deny OTC approval of Barr's Plan B (levenorgestrel) emergency contraceptive
Plan B Decision Mobilizes House Members To Seek FDA Integrity Review
A House bill directing FDA to conduct a formal review of the process leading up to its decision to designate as "not approvable" the Rx-to-OTC switch application for the Plan B emergency contraceptive was introduced by Rep. Carolyn Maloney (D-N.Y.) on May 14
CDER’s Galson Cites Application Flaws, Not Politics, In Plan B Decision
Barr Labs submitted a marketing plan for behind-the-counter sale of Plan B (levonorgestrel .75 mg), but FDA was "unable" to review the package